Recruiting Ankylosing Spondylitis Studies in Davie
A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)
This is a clinical trial assessing the safety and tolerability of an investigational drug, VRDN-003, in participants with Thyroid Eye Disease (TED)....
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
This study will be evaluating the safety and efficacy of insulin and glutathione in subjects with Parkinson's Disease compared to placebo....
About Ankylosing Spondylitis Clinical Trials in Davie
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Davie, FL. These studies are seeking a combined 340 participants. Research is being sponsored by Viridian Therapeutics, Inc., Gateway Institute for Brain Research. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Davie — FAQ
Are there ankylosing spondylitis clinical trials in Davie?
Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Davie, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Davie?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Davie research site will contact you about next steps.
Are clinical trials in Davie free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Davie studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 2 active trials in Davie are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated March 2, 2026 from ClinicalTrials.gov